1. Screening Libraries
  2. Protein Tyrosine Kinase Compound Library

Protein Tyrosine Kinase Compound Library

Cat. No.: HY-L016
Library Contents: XLSX PDF

A unique collection of 318 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at


Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

& Advantages

•   A unique collection of 318 protein kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

•   Targets such as VEGFR, ALK, Btk, Bcr-Abl, c-Met/HGFR, EGFR, FGFR, Insulin Receptor, JAK, PDGFR, etc.

•   A useful tool for the research for PTK-related diseases, such as cancer.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some protein kinase inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active and cell permeable.

•   Rich documentation with structure, IC50 and summary.

•   NMR and HPLC to ensure the high purity.

•   All compounds are in stock and continuously updated.

Product Details
A collection of 318 protein kinase inhibitors supplied as pre-dissolved DMSO solutions or Solid
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Blue ice

Protein Tyrosine Kinase Compound Library

Source: MedChem Express

Contents of Protein Tyrosine Kinase Compound Library

Plate layout: HY-L016-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty NT157 EAI045 NVP-BAW2881 AEE788 TPI-1 GSK2256098 Tyrphostin AG 528 NPS-1034 MSDC 0160 LM22A-4 Empty
b Empty TAK-659 (hydrochloride) CEP-40783 HA-100 Src Inhibitor 1 PD-166866 RG14620 RG13022 ISCK03 SUN11602 Nilotinib Empty
c Empty Nilotinib (monohydrochloride monohydrate) Dasatinib Dasatinib (hydrochloride) Linsitinib NVP-TAE 684 BTK IN-1 BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib Empty
d Empty OSI-930 Cediranib Amuvatinib Dovitinib (lactate) Pazopanib Masitinib Masitinib (mesylate) CUDC-101 Motesanib Motesanib (Diphosphate) Empty
e Empty Saracatinib RAF265 NVP-ADW742 AG1024 Sunitinib Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 TPX-0005 Empty
f Empty PD173074 BIBX 1382 CL-387785 Toceranib Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 Empty
g Empty KX2-391 (dihydrochloride) KX2-391 (Mesylate) Fasudil (Hydrochloride) Canertinib (dihydrochloride) PP121 SU5416 PD173955 SU 5402 TG101209 PF-562271 (besylate) Empty
h Empty PF-562271 PF-573228 BMS-794833 SU14813 SU14813 (maleate) Orantinib GSK1904529A Telatinib ARRY-380 (analog ) Ningetinib Tosylate Empty

Plate layout: HY-L016-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Ningetinib 2-Phospho-L-ascorbic acid trisodium salt EG00229 Lazertinib GW2580 GNF-7 FLT3-IN-1 Tivozanib Lenvatinib ENMD-2076 (Tartrate) Empty
b Empty ENMD-2076 MGCD-265 analog PCI-32765 GNF-2 CGP60474 BIBF 1120 (esylate) PHA-665752 R406 (free base) eCF506 BMS-986195 Empty
c Empty CGI-1746 AG-490 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) PD153035 (Hydrochloride) SU11274 PF-04217903 PF-04217903 (methanesulfonate) Vatalanib (dihydrochloride) Empty
d Empty SGX-523 WZ4002 AMG-208 Ki8751 Lyn-IN-1 Cabozantinib (S-malate) Ponatinib CP-673451 AT7867 AT7867 (dihydrochloride) Empty
e Empty KRN-633 R406 DPH Lck Inhibitor BMS 777607 PF-06463922 AZ191 Defactinib Defactinib (hydrochloride) WH-4-023 Empty
f Empty KRCA-0008 UNC2025 UNC2025 (hydrochloride) Gilteritinib Y15 LDC1267 ANA-12 Entrectinib BLZ945 BLU9931 Empty
g Empty Mirk-IN-1 LOXO-101 (sulfate) TP-0903 SGI-7079 S49076 PRT-060318 Quizartinib CH5424802 CH5424802 (Hydrochloride) Cabozantinib Empty
h Empty GSK1838705A DCC-2036 LY2784544 R788(Disodium) R788 (disodium hexahydrate) Cediranib (maleate) Sapitinib E-7050 NVP-TAE 226 Crenolanib Empty

Plate layout: HY-L016-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty OSI-420 NVP-BHG712 CHIR-124 WP1130 Dacomitinib IRAK inhibitor 1 IRAK inhibitor 2 IRAK inhibitor 3 IRAK inhibitor 6 LY2874455 Empty
b Empty Regorafenib (Hydrochloride) NVP-BGJ398 NVP-BGJ398 (phosphate) ASP3026 IRAK-1-4 Inhibitor I AZD4547 Apatinib INCB28060 ALK-IN-1 GNF-5837 Empty
c Empty Mubritinib Piceatannol Nocodazole AG-1478 BPR1J-097 Hydrochloride AZM475271 Chrysophanol (-)-Epigallocatechin Gallate PQ401 Oglufanide Empty
d Empty R1530 ZM 306416 PP1 PP2 PLX647 WHI-P154 PD168393 CNX-2006 Flumatinib Flumatinib (mesylate) Empty
e Empty TCS 359 PND-1186 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) CNX-774 DDR1-IN-1 PD153035 PF-03814735 Genistein CP-724714 Empty
f Empty EMD-1214063 BAY 61-3606 (dihydrochloride) AST 487 Icotinib (Hydrochloride) Icotinib SB1317 TAK-285 c-Kit-IN-1 AIM-100 PRT062607 (Hydrochloride) Empty
g Empty AG 555 ALK inhibitor 2 NVP-BVU972 SAR131675 Imatinib ZM323881 (hydrochloride) AXL1717 Tyrphostin A9 LY2801653 SSR128129E Empty
h Empty AZD-3463 AG 18 LDK378 LDK378 (dihydrochloride) GZD824 CO-1686 CO-1686 (hydrobromide) Poziotinib GNF-5 XL228 Empty

Plate layout: HY-L016-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty A 419259 (trihydrochloride) ONO-4059 ONO-4059 (hydrochloride) AZD-9291 AZD-9291 (mesylate) UNC2250 UNC2881 ID-8 CEP-37440 AMG 925 (HCl) Empty
b Empty GS-9973 H-89 (dihydrochloride) Cerdulatinib Irbinitinib AT13148 JI-101 Pacritinib Butein Pexidartinib Sitravatinib Empty
c Empty Acalabrutinib Belizatinib LFM-A13 AVL-292 CEP-28122 (mesylate salt) CCT241736 AZD2932 GW 441756 FIIN-2 PD158780 Empty
d Empty AMG-337 Erdafitinib SCR-1481B1 AZD3759 ONO-4059 (analog) NVP-ACC789 MCB-613 Olmutinib Avitinib (maleate) GDC-0853 Empty
e Empty PF06650833 Fruquintinib CH5183284 PF-06459988 Tyrphostin AG 879 Pelitinib Neratinib JNJ-38877605 Tivantinib Linifanib Empty
f Empty Bafetinib Crizotinib Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Lapatinib Lapatinib (ditosylate) BIBF 1120 Dovitinib Empty
g Empty Imatinib (Mesylate) Tolimidone MNS Bucladesine (sodium salt) Bucladesine (calcium salt) SU6656 Altiratinib AZ-5104 Trapidil Ginsenoside Rb1 Empty
h Empty Ferulic acid Neohesperidin dihydrochalcone Formononetin Harmine Scutellarein 7-Hydroxy-4H-chromen-4-one Protein kinase inhibitors 1 hydrochloride 2,5-Dihydroxybenzoic acid Empty Empty Empty


Your information is safe with us. * Required Fields.



* 需求量:

* 客户姓名:


* Email:

* 电话:


* 公司或机构名称:


Bulk Inquiry

Inquiry Information

Protein Tyrosine Kinase Compound Library

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.